Brimonidine
Also sold as: Simbrinza, Mirvaso, Lumify, Alphagan, Combigan
Related Medications
These drugs share a pharmacologic classification but are NOT interchangeable. Listing here does not imply clinical equivalence. A physician must evaluate each drug individually for the patient's specific condition.
Classification: Adrenergic alpha-Agonists (source: RxClass/NLM)
- apraclonidinealpha-Adrenergic AgonistSame Class
- clonidinealpha-Adrenergic AgonistSame Class
- ephedrinealpha-Adrenergic AgonistSame Class
- epinephrinealpha-Adrenergic AgonistSame Class
- guanfacinealpha-Adrenergic AgonistSame Class
- dexmedetomidinealpha-Adrenergic AgonistSame Class
- guanabenzalpha-Adrenergic AgonistSame Class
- tizanidinealpha-Adrenergic AgonistSame Class
- midodrinealpha-Adrenergic AgonistSame Class
- phenylephrinealpha-Adrenergic AgonistSame Class
- pseudoephedrinealpha-Adrenergic AgonistSame Class
- mirabegronAdrenergic Receptor AgonistSame Class
- vilanterolAdrenergic Receptor AgonistSame Class
- olodaterolAdrenergic Receptor AgonistSame Class
- levalbuterolAdrenergic Receptor AgonistSame Class
Insurance Coverage User-Reported
No community coverage data yet for brimonidine.
Coverage data submission coming soon.
Drug Information
Indications & Uses
Use relieves redness of the eye due to minor eye irritations
Dosage & Administration
Directions adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface replace cap after each use children under 5 years of age: consult a doctor
Warnings & Precautions
Warnings For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Verify with Primary Sources
Always verify clinical information with authoritative sources.
Medical Disclaimer: Information on this page is sourced from FDA-approved labeling data and is for educational reference only. It does not constitute medical advice. This information does not establish a provider-patient relationship. Always verify with current prescribing information and consult a licensed healthcare professional before any clinical decision. Read full disclaimer.
Data sourced from RxNorm (NLM/NIH), FDA Orange Book, OpenFDA, DailyMed. Last updated: 2026-03-02.